Eculizumab administration

DRUG3 trials

Sponsors

University Hospital, Rouen, Huashan Hospital, Tianjin Medical University General Hospital

Conditions

Neuromyelitis Optica Spectrum Disorders (NMOSD)Thrombotic Microangiopathies

Phase 3

Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies

WithdrawnNCT05702996

University Hospital, RouenThrombotic Microangiopathies

Start: 2023-03-01End: 2025-09-01Updated: 2026-06-09

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

RecruitingNCT07420296

Tianjin Medical University General HospitalNeuromyelitis Optica Spectrum Disorders (NMOSD)

Start: 2026-01-01End: 2027-06-30Target: 198Updated: 2026-05-14

Unknown Phase

BLAZE-Limiting Approach in NMOSD

CompletedNCT06888622

Huashan HospitalNeuromyelitis Optica Spectrum Disorders (NMOSD)

Start: 2023-10-01End: 2025-03-03Updated: 2025-03-21